Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 31, Issue 3, Pages 190-196
Publisher
Informa UK Limited
Online
2013-03-12
DOI
10.3109/07357907.2013.775293
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
- (2012) Gérald Raverot et al. CLINICAL ENDOCRINOLOGY
- Clinically silent somatotroph adenomas are common
- (2011) Alisha N Wade et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
- (2011) Fateme Salehi et al. JOURNAL OF NEURO-ONCOLOGY
- Treatment of pituitary neoplasms with temozolomide
- (2010) Luis V. Syro et al. CANCER
- Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
- (2010) Gérald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide-induced inhibition of pituitary adenoma cells
- (2010) Jason Sheehan et al. JOURNAL OF NEUROSURGERY
- Atypical pituitary adenomas: incidence, clinical characteristics, and implications
- (2010) Gabriel Zada et al. JOURNAL OF NEUROSURGERY
- MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
- (2010) Queenie Lau et al. Pituitary
- Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly
- (2010) Emilie Morin et al. Pituitary
- The epidemiology and genetics of pituitary adenomas
- (2009) Adrian F. Daly et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation
- (2009) Andrea G. Lania et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Possible role of a radiation-induced p53 mutation in a Nelson’s syndrome patient with a fatal outcome
- (2009) Emilia Modolo Pinto et al. Pituitary
- Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
- (2008) D. Erickson et al. CLINICAL ENDOCRINOLOGY
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Modification of hormonal secretion in clinically silent pituitary adenomas
- (2008) Tania Daems et al. Pituitary
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More